How is Flotufolastat F 18 dosed?
Flotufolastat F 18 is administered intravenously and the dosage is based on body weight. It is used in conjunction with a PET scan to detect PSMA positive lesions in men with prostate cancer who are candidates for initial treatment or suspected recurrence.
What is the dosage form of Flotufolastat F 18?
The dosage form of Flotufolastat F 18 is a solution for intravenous administration.
How is Flotufolastat F 18 administered?
Flotufolastat F 18 is administered through an intravenous (IV) route under the direct supervision of a healthcare professional with specialized training in nuclear medicine.
What are common precautions when taking Flotufolastat F 18?
Common precautions when taking Flotufolastat F 18 include:
- Allergies: Inform your doctor about any unusual or allergic reactions to this medicine or other medicines, as well as any other types of allergies.
- Pregnancy and Breastfeeding: Consult your doctor regarding the potential risks and benefits of using Flotufolastat F 18 during pregnancy or breastfeeding.
- Pediatric Use: Safety and efficacy of Flotufolastat F 18 have not been established in the pediatric population.
It is important to follow your doctor's instructions and undergo the procedure only under the direct supervision of a healthcare professional with specialized training in nuclear medicine.